Valo Therapeutics Company
Valo Therapeutics is an immunooncology company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.
Headquarters:
Helsinki, Southern Finland, Finland
Last Funding Date:
2020-02-06
Funding Status:
Seed
Investors Number:
1
Founded Date:
2016-01-01
Last Funding Type:
Debt Financing
Employee Number:
11-50
Total Funding:
9207932
Industry:
Viral Vectors
Estimated Revenue:
$10M to $50M